Medical technology giant Medtronic plc MDT recently completed the acquisition of HeartWare International, Inc. HTWR – a global medical device manufacturer dedicated to serve patients with advanced ...
Heartware International (HTWR) is watching its shares absolutely skyrocket in Monday's session despite the huge market downturn from the Brexit. This surge is the result of Medtronic PLC (MDT) moving ...
The FDA's Circulatory System Devices panel voted 9-2 on Wednesday to recommend approval of the HeartWare Ventricular Assist System as a bridge to heart transplantation for patients with end-stage ...
The FDA said today that it had granted approval to the HeartWare Ventricular Assist System for use in heart failure patients waiting for a transplant. Approval of the device had been expected after ...
The US Food and Drug Administration (FDA) is notifying physicians of a Class I recall of unimplanted HeartWare ventricular assist device (VAD) implant kits, initiated voluntarily by the company in ...
Medtronic PLCMDT-1.42%decrease; down pointing triangle said Monday that it agreed to acquire HeartWare International Inc. for $1.1 billion, adding more heart-treatment products to the medical-device ...
FRAMINGHAM, MA — The US Food and Drug Administration issued a formal warning to the makers of a recently approved ventricular assist device (VAD) system (HeartWare, Framingham, MA) for failing to take ...
Shares of HeartWare International jumped 14 percent before the market opened Thursday, after a heart pump made by the company received a positive recommendation from a regulatory panel. The Food and ...
MVAD, HeartWare's next-generation left ventricular assist device (LVAD), isn't yet ready to be studied again in humans, but when it is, expect a new study. That was the message from HeartWare ...
On 22 March 2006, a 48 year old male patient suffering NYHA Class IV Heart Failure became the first recipient of HeartWare's HVAD mechanical circulatory assist device. The implant was conducted at the ...
FRAMINGHAM, Mass. and SYDNEY, Australia, April 18 HeartWare Limited (ASX: HTW) today announced that it is moving to an expanded,upgraded manufacturing facility in Miami Lakes, FL, USA. The new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results